ID   S26A2_HUMAN             Reviewed;         739 AA.
AC   P50443; A8K2U3; B2R6J1; Q6N051;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Sulfate transporter;
DE   AltName: Full=Diastrophic dysplasia protein;
DE   AltName: Full=Solute carrier family 26 member 2;
GN   Name=SLC26A2; Synonyms=DTD, DTDST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT THR-574, FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7923357; DOI=10.1016/0092-8674(94)90281-X;
RA   Haestbacka J., de la Chapelle A., Mahtani M.M., Clines G.,
RA   Reeve-Daly M.P., Daly M., Hamilton B.A., Kusumi K., Trivedi B.,
RA   Weaver A., Coloma A., Lovett M., Buckler A., Kaitila I., Lander E.S.;
RT   "The diastrophic dysplasia gene encodes a novel sulfate transporter:
RT   positional cloning by fine-structure linkage disequilibrium mapping.";
RL   Cell 78:1073-1087(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-574.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-574.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 614-739.
RC   TISSUE=Prostate;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-16, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   VARIANTS ACG1B VAL-340 DEL; ASP-425 AND VAL-678.
RX   PubMed=8528239; DOI=10.1038/ng0196-100;
RA   Superti-Furga A., Haestbacka J., Wilcox W.R., Cohn D.H.,
RA   van der Harten H.J., Rossi A., Blau N., Rimoin D.L., Steinmann B.,
RA   Lander E.S., Gitzelmann R.;
RT   "Achondrogenesis type IB is caused by mutations in the diastrophic
RT   dysplasia sulphate transporter gene.";
RL   Nat. Genet. 12:100-102(1996).
RN   [9]
RP   VARIANTS AO2 GLU-255; TRP-279 AND VAL-715.
RX   PubMed=8571951;
RA   Haestbacka J., Superti-Furga A., Wilcox W.R., Rimoin D.L., Cohn D.H.,
RA   Lander E.S.;
RT   "Atelosteogenesis type II is caused by mutations in the diastrophic
RT   dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic
RT   series involving three chondrodysplasias.";
RL   Am. J. Hum. Genet. 58:255-262(1996).
RN   [10]
RP   VARIANT DIATROPHIC DYSPLASIA PRO-454.
RX   PubMed=10466420; DOI=10.1034/j.1399-0004.1999.560110.x;
RA   Megarbane A., Haddad F.A., Haddad-Zebouni S., Achram M., Eich G.,
RA   Le Merrer M., Superti-Furga A.;
RT   "Homozygosity for a novel DTDST mutation in a child with a 'broad
RT   bone-platyspondylic' variant of diastrophic dysplasia.";
RL   Clin. Genet. 56:71-76(1999).
RN   [11]
RP   VARIANT EDM4 SER-653.
RX   PubMed=12966518; DOI=10.1002/ajmg.a.20282;
RA   Maekitie O., Savarirayan R., Bonafe L., Robertson S., Susic M.,
RA   Superti-Furga A., Cole W.G.;
RT   "Autosomal recessive multiple epiphyseal dysplasia with homozygosity
RT   for C653S in the DTDST gene: double-layer patella as a reliable
RT   sign.";
RL   Am. J. Med. Genet. A 122:187-192(2003).
RN   [12]
RP   VARIANTS EDM4 SER-256; TRP-279; SER-653 AND VAL-715.
RX   PubMed=21922596; DOI=10.1002/humu.21611;
RA   Jackson G.C., Mittaz-Crettol L., Taylor J.A., Mortier G.R.,
RA   Spranger J., Zabel B., Le Merrer M., Cormier-Daire V., Hall C.M.,
RA   Offiah A., Wright M.J., Savarirayan R., Nishimura G., Ramsden S.C.,
RA   Elles R., Bonafe L., Superti-Furga A., Unger S., Zankl A.,
RA   Briggs M.D.;
RT   "Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year
RT   comprehensive analysis of the known disease genes identify novel and
RT   recurrent mutations and provides an accurate assessment of their
RT   relative contribution.";
RL   Hum. Mutat. 33:144-157(2012).
CC   -!- FUNCTION: Sulfate transporter. May play a role in endochondral
CC       bone formation. {ECO:0000269|PubMed:7923357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7923357};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:7923357}.
CC   -!- DISEASE: Diastrophic dysplasia (DTD) [MIM:222600]: An autosomal
CC       recessive disease characterized by osteochondrodysplasia with
CC       clinical features including dwarfism, spinal deformation, and
CC       specific joint abnormalities. {ECO:0000269|PubMed:10466420}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Achondrogenesis 1B (ACG1B) [MIM:600972]: A form of
CC       achondrogenesis type 1, a lethal form of chondrodysplasia
CC       characterized by deficient ossification in the lumbar vertebrae
CC       and absent ossification in the sacral, pubic and ischial bones and
CC       clinically by stillbirth or early death. In addition to severe
CC       micromelia, there is a disproportionately large cranium due to
CC       marked edema of soft tissues. {ECO:0000269|PubMed:8528239}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Atelosteogenesis 2 (AO2) [MIM:256050]: A perinatal
CC       dysplasia characterized by shortening of the limbs, a dysmorphic
CC       syndrome and radiographic skeletal features. Patients are
CC       stillborn or die soon after birth. {ECO:0000269|PubMed:8571951}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Multiple epiphyseal dysplasia 4 (EDM4) [MIM:226900]: A
CC       generalized skeletal dysplasia associated with significant
CC       morbidity. Joint pain, joint deformity, waddling gait, and short
CC       stature are the main clinical signs and symptoms. Radiological
CC       examination of the skeleton shows delayed, irregular
CC       mineralization of the epiphyseal ossification centers and of the
CC       centers of the carpal and tarsal bones. Multiple epiphyseal
CC       dysplasia is broadly categorized into the more severe Fairbank and
CC       the milder Ribbing types. The Fairbank type is characterized by
CC       shortness of stature, short and stubby fingers, small epiphyses in
CC       several joints, including the knee, ankle, hand, and hip. The
CC       Ribbing type is confined predominantly to the hip joints and is
CC       characterized by hands that are normal and stature that is normal
CC       or near-normal. Multiple epiphyseal dysplasia type 4 is a
CC       recessively inherited form, characterized by early childhood-onset
CC       hip dysplasia and recurrent patella dislocation. Short stature is
CC       not frequent. {ECO:0000269|PubMed:12966518,
CC       ECO:0000269|PubMed:21922596}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SLC26A/SulP transporter (TC 2.A.53)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U14528; AAA70081.1; -; mRNA.
DR   EMBL; AK290358; BAF83047.1; -; mRNA.
DR   EMBL; AK312596; BAG35488.1; -; mRNA.
DR   EMBL; AC008427; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61755.1; -; Genomic_DNA.
DR   EMBL; BC059390; AAH59390.1; -; mRNA.
DR   EMBL; BX640696; CAE45819.1; -; mRNA.
DR   CCDS; CCDS4300.1; -.
DR   PIR; A54808; A54808.
DR   RefSeq; NP_000103.2; NM_000112.3.
DR   RefSeq; XP_016864680.1; XM_017009191.1.
DR   UniGene; Hs.302738; -.
DR   ProteinModelPortal; P50443; -.
DR   BioGrid; 108169; 13.
DR   IntAct; P50443; 1.
DR   MINT; MINT-5001062; -.
DR   STRING; 9606.ENSP00000286298; -.
DR   TCDB; 2.A.53.2.1; the sulfate permease (sulp) family.
DR   iPTMnet; P50443; -.
DR   PhosphoSitePlus; P50443; -.
DR   SwissPalm; P50443; -.
DR   BioMuta; SLC26A2; -.
DR   DMDM; 254763328; -.
DR   EPD; P50443; -.
DR   MaxQB; P50443; -.
DR   PaxDb; P50443; -.
DR   PeptideAtlas; P50443; -.
DR   PRIDE; P50443; -.
DR   Ensembl; ENST00000286298; ENSP00000286298; ENSG00000155850.
DR   GeneID; 1836; -.
DR   KEGG; hsa:1836; -.
DR   UCSC; uc003lrh.4; human.
DR   CTD; 1836; -.
DR   DisGeNET; 1836; -.
DR   GeneCards; SLC26A2; -.
DR   GeneReviews; SLC26A2; -.
DR   H-InvDB; HIX0005307; -.
DR   HGNC; HGNC:10994; SLC26A2.
DR   HPA; HPA041957; -.
DR   HPA; HPA058090; -.
DR   MalaCards; SLC26A2; -.
DR   MIM; 222600; phenotype.
DR   MIM; 226900; phenotype.
DR   MIM; 256050; phenotype.
DR   MIM; 600972; phenotype.
DR   MIM; 606718; gene.
DR   neXtProt; NX_P50443; -.
DR   OpenTargets; ENSG00000155850; -.
DR   Orphanet; 93298; Achondrogenesis type 1B.
DR   Orphanet; 56304; Atelosteogenesis type II.
DR   Orphanet; 628; Diastrophic dwarfism.
DR   Orphanet; 93307; Multiple epiphyseal dysplasia type 4.
DR   PharmGKB; PA149; -.
DR   eggNOG; KOG0236; Eukaryota.
DR   eggNOG; COG0659; LUCA.
DR   GeneTree; ENSGT00760000119026; -.
DR   HOGENOM; HOG000006546; -.
DR   HOVERGEN; HBG000639; -.
DR   InParanoid; P50443; -.
DR   KO; K14701; -.
DR   OMA; YPRIHME; -.
DR   OrthoDB; EOG091G07RT; -.
DR   PhylomeDB; P50443; -.
DR   TreeFam; TF313784; -.
DR   Reactome; R-HSA-174362; Transport and synthesis of PAPS.
DR   Reactome; R-HSA-427601; Multifunctional anion exchangers.
DR   ChiTaRS; SLC26A2; human.
DR   GeneWiki; SLC26A2; -.
DR   GenomeRNAi; 1836; -.
DR   PRO; PR:P50443; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000155850; -.
DR   CleanEx; HS_SLC26A2; -.
DR   ExpressionAtlas; P50443; baseline and differential.
DR   Genevisible; P50443; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015301; F:anion:anion antiporter activity; IBA:GO_Central.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0019531; F:oxalate transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015116; F:sulfate transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome.
DR   GO; GO:0015701; P:bicarbonate transport; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0001503; P:ossification; IEA:Ensembl.
DR   GO; GO:0051453; P:regulation of intracellular pH; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:1902358; P:sulfate transmembrane transport; IMP:UniProtKB.
DR   Gene3D; 3.30.750.24; -; 1.
DR   InterPro; IPR018045; S04_transporter_CS.
DR   InterPro; IPR011547; SLC26A/SulP_dom.
DR   InterPro; IPR001902; SLC26A/SulP_fam.
DR   InterPro; IPR030280; SLC26A2.
DR   InterPro; IPR002645; STAS_dom.
DR   PANTHER; PTHR11814; PTHR11814; 1.
DR   PANTHER; PTHR11814:SF158; PTHR11814:SF158; 1.
DR   Pfam; PF01740; STAS; 1.
DR   Pfam; PF00916; Sulfate_transp; 1.
DR   SUPFAM; SSF52091; SSF52091; 2.
DR   TIGRFAMs; TIGR00815; sulP; 1.
DR   PROSITE; PS01130; SLC26A; 1.
DR   PROSITE; PS50801; STAS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Dwarfism;
KW   Glycoprotein; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    739       Sulfate transporter.
FT                                /FTId=PRO_0000080158.
FT   TRANSMEM    112    132       Helical. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TRANSMEM    242    262       Helical. {ECO:0000255}.
FT   TRANSMEM    378    398       Helical. {ECO:0000255}.
FT   TRANSMEM    420    440       Helical. {ECO:0000255}.
FT   TRANSMEM    455    475       Helical. {ECO:0000255}.
FT   TRANSMEM    524    544       Helical. {ECO:0000255}.
FT   DOMAIN      568    719       STAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00198}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CARBOHYD    199    199       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    357    357       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     255    255       G -> E (in AO2; dbSNP:rs104893917).
FT                                {ECO:0000269|PubMed:8571951}.
FT                                /FTId=VAR_007434.
FT   VARIANT     256    256       F -> S (in EDM4).
FT                                {ECO:0000269|PubMed:21922596}.
FT                                /FTId=VAR_066835.
FT   VARIANT     279    279       R -> W (in AO2 and EDM4;
FT                                dbSNP:rs104893915).
FT                                {ECO:0000269|PubMed:21922596,
FT                                ECO:0000269|PubMed:8571951}.
FT                                /FTId=VAR_007435.
FT   VARIANT     340    340       Missing (in ACG1B).
FT                                {ECO:0000269|PubMed:8528239}.
FT                                /FTId=VAR_007436.
FT   VARIANT     425    425       N -> D (in ACG1B; dbSNP:rs104893920).
FT                                {ECO:0000269|PubMed:8528239}.
FT                                /FTId=VAR_007437.
FT   VARIANT     454    454       Q -> P (in diatrophic dysplasia; broad
FT                                bone-platyspondylic variant;
FT                                dbSNP:rs104893921).
FT                                {ECO:0000269|PubMed:10466420}.
FT                                /FTId=VAR_018654.
FT   VARIANT     574    574       I -> T (in dbSNP:rs30832).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7923357}.
FT                                /FTId=VAR_058415.
FT   VARIANT     653    653       C -> S (in EDM4; dbSNP:rs104893924).
FT                                {ECO:0000269|PubMed:12966518,
FT                                ECO:0000269|PubMed:21922596}.
FT                                /FTId=VAR_018655.
FT   VARIANT     678    678       G -> V (in ACG1B; dbSNP:rs104893916).
FT                                {ECO:0000269|PubMed:8528239}.
FT                                /FTId=VAR_007438.
FT   VARIANT     689    689       T -> S (in dbSNP:rs3776070).
FT                                /FTId=VAR_020402.
FT   VARIANT     715    715       A -> V (in AO2 and EDM4;
FT                                dbSNP:rs104893918).
FT                                {ECO:0000269|PubMed:21922596,
FT                                ECO:0000269|PubMed:8571951}.
FT                                /FTId=VAR_007439.
FT   CONFLICT    619    619       R -> G (in Ref. 6; CAE45819).
FT                                {ECO:0000305}.
FT   CONFLICT    622    622       K -> R (in Ref. 2; BAG35488).
FT                                {ECO:0000305}.
SQ   SEQUENCE   739 AA;  81662 MW;  577984D0E973087F CRC64;
     MSSESKEQHN VSPRDSAEGN DSYPSGIHLE LQRESSTDFK QFETNDQCRP YHRILIERQE
     KSDTNFKEFV IKKLQKNCQC SPAKAKNMIL GFLPVLQWLP KYDLKKNILG DVMSGLIVGI
     LLVPQSIAYS LLAGQEPVYG LYTSFFASII YFLLGTSRHI SVGIFGVLCL MIGETVDREL
     QKAGYDNAHS APSLGMVSNG STLLNHTSDR ICDKSCYAIM VGSTVTFIAG VYQVAMGFFQ
     VGFVSVYLSD ALLSGFVTGA SFTILTSQAK YLLGLNLPRT NGVGSLITTW IHVFRNIHKT
     NLCDLITSLL CLLVLLPTKE LNEHFKSKLK APIPIELVVV VAATLASHFG KLHENYNSSI
     AGHIPTGFMP PKVPEWNLIP SVAVDAIAIS IIGFAITVSL SEMFAKKHGY TVKANQEMYA
     IGFCNIIPSF FHCFTTSAAL AKTLVKESTG CHTQLSGVVT ALVLLLVLLV IAPLFYSLQK
     SVLGVITIVN LRGALRKFRD LPKMWSISRM DTVIWFVTML SSALLSTEIG LLVGVCFSIF
     CVILRTQKPK SSLLGLVEES EVFESVSAYK NLQIKPGIKI FRFVAPLYYI NKECFKSALY
     KQTVNPILIK VAWKKAAKRK IKEKVVTLGG IQDEMSVQLS HDPLELHTIV IDCSAIQFLD
     TAGIHTLKEV RRDYEAIGIQ VLLAQCNPTV RDSLTNGEYC KKEEENLLFY SVYEAMAFAE
     VSKNQKGVCV PNGLSLSSD
//
